We investigated CTCs in metastatic breast cancer patients. In our study, higher CTC-levels were found in patients with positive lymphnodes at the time of diagnosis, with bone metastases and with elevated CA-15-3- and CRP-levels (http://www.biomedcentral.com/1471-2407/12/206/abstract).